Overview of Could A Smart Inhaler Add-On Be A Lifesaver For COPD And Asthma Patients?
Aptar Pharma introduced HeroTracker Sense, a sensor-equipped add-on that converts metered dose inhalers into connected devices to support patients with chronic respiratory conditions by monitoring inhalation technique, flow rate, and timing. The device pairs with the BreatheSmart app for adherence reminders and environmental warnings, and its data can be accessed via a HIPAA- and GDPR-compliant BreatheSmart Connect Portal for clinicians. CE marked and developed under ISO 13485, HeroTracker Sense is pending FDA approval and aims to generate real-world evidence to support patient care and reimbursement models.
Quick Solutions to Questions related to HeroTracker Sense:
-
What is HeroTracker Sense?
HeroTracker Sense is a sensor add-on that attaches to inhaler canisters to convert metered dose inhalers into connected devices that monitor inhalation technique, flow rate, and timing. -
How does HeroTracker Sense help patients?
It supports proper inhalation technique and adherence by coordinating inspiration with actuation, measuring flow rate and inhalation length, and providing date and time adherence reminders via the BreatheSmart app. -
Can clinicians access patient data from HeroTracker Sense?
Yes, clinicians can access statistics and insights through the HIPAA- and GDPR-compliant BreatheSmart Connect Portal for training, onboarding, and performance monitoring. -
What regulatory status does HeroTracker Sense have?
HeroTracker Sense is CE marked, was developed under an ISO 13485 certified Quality Management System, and is pending FDA approval. -
Does the BreatheSmart app provide environmental warnings?
Yes, Aptar says the BreatheSmart app includes environmental monitoring warnings on temperature and humidity in addition to adherence timestamps.
Aptar Pharma has introduced a novel linked gadget that has the potential to transform traditional metered dosage inhalers into smart connected devices. HeroTracker Sense was created to aid patients suffering from chronic respiratory disorders caused by COVID-19, such as asthma, COPD, cystic fibrosis, and other respiratory ailments, by supporting proper inhalation technique and adherence.

HeroTracker Sense uses sensors to facilitate coordination of inspiration with actuation, flow rate, and inhalation length. It is designed to attach to an inhaler canister. According to Aptar Pharma, the BreatheSmart app includes date and time stamps to show when patients should take their prescription, as well as environmental monitoring warnings on temperature and humidity.
“The launch of HeroTracker Sense establishes Aptar’s digital respiratory portfolio as a world-class solution, delivering insights into patient behaviors and how they will affect how the patient interacts with their device and understands their indication.” In the release, Marcus Bates, director, business development, digital healthcare, Aptar Pharma, stated, “We see this as a product for the future and one that will demonstrate significant value, creating real-world evidence that can aid the support of reimbursement models in numerous different markets.”
More: Sensors Could Enhance Health Care At Home
The Aptar Pharma Cohero Health BreatheSmart Connect Portal, which is both HIPAA and GDPR compliant, may also give healthcare practitioners important statistics and insights about patient training, onboarding, and performance, according to the business.
“HeroTracker Sense is a strategic addition to Aptar’s portfolio of digital health solutions in the respiratory space,” said Sai Shankar, president of Aptar Pharma’s digital health division. “It highlights Aptar Pharma’s progress in the field of digital therapeutics, as well as our commitment to providing tools that will improve the lives of patients.”
HeroTracker Sense has been designed and developed using Aptar Digital Health’s ISO 13485 certified Quality Management System; it is CE marked and is pending FDA approval.
In 2020, Aptar Pharma worked with Lupin Limited on Adhero, reportedly India’s first “connected device” for metered-dose inhalers. Adhero attaches to the top of an inhaler.




